← FDA Drug Approvals (Drugs@FDA)

STAVUDINE; LAMIVUDINE; NEVIRAPINE

NDA · New Drug Application · Sponsor: EMCURE PHARMA · Approved 2009-07-16

Drug application

FDA Application #

NDA022342

Application type

New Drug Application

Brand name

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Generic name

Stavudine

Active ingredients

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

EMCURE PHARMA

First approval

2009-07-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown